Several clinical studies highlight increased body mass index as a protective factor through the immunomodulatory effect of obesity secondary to increased serum levels of interleukins with an anti-inflammatory role (IL-4, IL-13) [33,34]. Here, IL13 is linked to obesity due to melanocortin 4 receptor deficiency.